Anatomy-aware Fine-grained Multimodal Fusion for Laryngopharyngeal Cancer T-Staging Prediction Using CT and Radiology Report.
Where this comes from
- Record sourced from PubMed, PMID 42546011.
- Also identified by DOI 10.1109/TMI.2026.3719112.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Accurate T-staging is crucial for guiding personalized treatment strategies for laryngopharyngeal cancer. However, current clinical practice relies on invasive biopsy procedures, whereas CT-based staging remains challenging due to the complex patterns of tumor invasion. Recent computer-aided approaches face two key challenges: 1) Structural relationship modeling: existing methods underrepresent anatomically structured patterns of tumor invasion, as they either process whole CT volumes without tumor-specific anatomical constraints or rely on labor-intensive tumor segmentation. 2) Fine-grained cross-modal alignment: while radiology reports contain organ-specific invasion details, current methods that apply global feature fusion struggle to accurately align individual anatomical structures with their corresponding textual descriptions. To address these issues, we propose an anatomy-aware multimodal framework that integrates organ-level CT context and radiology reports into a unified representation for laryngopharyngeal T-staging. The framework first constructs an Anatomy-Structured Organ Graph (AOG) that captures invasion patterns between primary sites and surrounding organs, then performs Organ-Anchored Cross-Modal Alignment (OCA) so that each organ node aggregates textual evidence from the radiology report, and finally refines this graph representation by injecting organ-specific invasion cues extracted from the report via Report-Enhanced Graph-Refinement (REG), yielding a multimodal organ graph that combines spatial and textual evidence. Extensive experiments demonstrate that the proposed framework achieves superior performance in T-staging of laryngopharyngeal cancer.